CompletedNCT04793685
Prazosin added to treatment for alcohol use and withdrawal symptoms
About this title
Prazosin for Alcohol Use Disorder With Withdrawal Symptoms
Read the official source — NCT04793685Medication studyAges 18–70United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- New HavenSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: July 1, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 152
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT04793685
- Official title
Show the full official title
Prazosin Treatment for Alcohol Use Disorder With Alcohol Withdrawal Symptoms
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Did this study involve medication?
Yes. The study involved medication, including Prazosin.
Who was this study for?
Listed age limits: 18 years to 70 years.
